
Balloon pulmonary angioplasty (BPA) showed more significant improvement in right ventricular (RV) afterload and function compared to riociguat in patients with inoperable chronic thromboembolic pulmonary hypertension. After 26 weeks, RV afterload improved more with BPA (P<0.001). Changes in RV afterload were driven by reduced pulmonary arterial pressure with BPA and increased cardiac output with riociguat. RV function improvements were only observed in the BPA group. The follow-up study confirmed BPA’s superior impact.
Like
Save
Share